BS

Binod Singh Gurjar

Active Director Director DIN 09024814
DIN 09024814 First appointment Jan 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Binod Singh Gurjar

Data last updated:

Binod Singh Gurjar is a Director at Nyctanthes Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare. Nyctanthes Pharmaceuticals Private Limited reported revenue of ₹83,133 (FY 2025).

DIN 09024814
Primary Designation Director
Industry Healthcare
First Appointment 09 Jan 2021
Oldest Company Age 5 yrs
Largest company Nyctanthes Pharmaceuticals Private Limited · ₹83,133 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jan 20212021₹83,133 (FY 2025)Active

Board colleagues of Binod Singh Gurjar

NameDINCompanyDesignation
Govind Sharan Singh09024815Nyctanthes Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nyctanthes Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Binod Singh Gurjar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Binod Singh Gurjar

Binod Singh Gurjar currently holds 1 directorship: Nyctanthes Pharmaceuticals Private Limited (Director, since 09 Jan 2021, revenue ₹83,133 (FY 2025)).

Binod Singh Gurjar was first appointed on 09 Jan 2021 as Director at Nyctanthes Pharmaceuticals Private Limited.

The current boards of Binod Singh Gurjar's companies include Govind Sharan Singh (Nyctanthes Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available